CDK7 and familial pancreatic carcinoma: Here, we used a sgRNA library focused on kinases and PDAC-associated genes and identified CDK7 as a candidate for chemotherapy sensitization in pancreatic cancer by adopting a systematic approach of negative selection of CRISPR-Cas9.